Log in
Enquire now
‌

US Patent 12018298 PH20 polypeptide variants, formulations and uses thereof

Patent 12018298 was granted and assigned to Halozyme, Inc. on June, 2024 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors
Patent abstract

Modified PH20 hyaluronidase polypeptides, including modified polypeptides that exhibit increased stability and/or increased activity, are provided. Also provided are compositions and formulations and uses thereof.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 12018298 PH20 polypeptide variants, formulations and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.